| J9271 | Injection, pembrolizumab, 1 mg | 29,200 | $40 | $1.3M |
| J9299 | Injection, nivolumab, 1 mg | 18,980 | $20 | $455.5K |
| J0897 | Injection, denosumab, 1 mg | 10,920 | $20 | $196.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,320 | $90 | $122.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 560 | $90 | $52.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 260 | $130 | $34.6K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 100 | $350 | $33.9K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,900 | $20 | $30.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 80 | $150 | $11.6K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 160 | $50 | $7.5K |